NASDAQ:CCXI

Chemocentryx Stock News

etoro logo Buy CCXI
*Your capital is at risk
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026

Insiders Roundup: Mastercard, ChemoCentryx

03:02pm, Friday, 17'th Jul 2020
Largest insider trades of the week Continue reading...
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Exane Derivatives decreased its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 24.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange C

Insiders Roundup: Mastercard, Eli Lilly

03:11pm, Friday, 10'th Jul 2020
Largest insider trades of the week Continue reading...
MOUNTAIN VIEW, Calif., July 09, 2020 -- ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug.
Stocks Analysis by Investing Insights covering: ChemoCentryx Inc, United Therapeutics Corporation, Axsome Therapeutics Inc. Read Investing Insights 's latest article on Investing.com
Disconnected. This seems to be the best way to describe the current economic environment. Amid high levels of unemployment and tanking earnings, stocks aren’t just hanging in there, they’re chargi
Investors need to pay close attention to ChemoCentryx (CCXI) stock based on the movements in the options market lately.

Top Small Cap Stocks for July 2020

04:53pm, Monday, 29'th Jun 2020
Small cap stocks are listed companies that have market capitalizations typically ranging from $300 million to $2 billion. Since the share prices of these companies can have big fluctuations over a sh
ChemoCentryx Inc (NASDAQ:CCXI) has received a consensus recommendation of “Buy” from the twelve ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock wit
Geode Capital Management LLC grew its position in ChemoCentryx Inc (NASDAQ:CCXI) by 10.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
EXCLUSIVE: Dylan, 7, from Doncaster, was given a radical new treatment for Focal Segmental Glomerulosclerosis (FSGS) after his mum emailed a US doctor out of the blue asking for help in treating her s
ChemoCentryx, Inc., (NASDAQ: CCXI) today announced that it has identified an orally administered checkpoint inhibitor, CCX559, and plans to initiate clinical
BNP Paribas Arbitrage SA boosted its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 207.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The i
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE